Just last week, I spent two days at the 2019 Cannabis Science Conference East here in my hometown of Baltimore, Md.
The operative word there is "science," and let me tell you, there is a lot of science driving the cannabis market forward that will lead to a ton of profit opportunities.
We're mapping genomes, studying plant fertilization, and learning how to prescribe cannabis to treat ailments as quickly and effectively as possible.
Over the course of two days, there were over 60 presentations covering topics ranging from equipment and methods to analyze cannabis plants, extracts, and cannabinoids; techniques to optimize cultivation; and the latest developments in medical cannabis research.
The companies most adept at deploying the latest science has to offer will enjoy much higher profit margins than those slow to adapt.
But the science goes far beyond the field or greenhouse.
About the Author
Greg Miller started working on Wall Street in September, 1987, just a month before the “Black Monday” stock market crash.
During his career there, he became an expert in just about every kind of publicly traded security - from blue-chip and small-cap stocks to municipals, junk bonds, and derivatives. As a portfolio manager, Greg was responsible for over $500 million of assets in mutual funds and insurance company accounts.
After leaving the Street, he designed a successful options trading strategy and made lucrative tech investments for a financial publication. He has also helped develop new products and worked with other editors to hone their strategies. He’s always been dedicated to deep, fundamental research - and he always will be - because he believes buying the very best companies at the right price is the best way to amass wealth in the stock market.